Investigation Overview
August 15, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Seres Therapeutics Inc (NASDAQ:MCRB) shares over potential securities laws violations by Seres Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the s...
You must register (for free) or login to view the entire investigation.